BIOLATTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 5.154
EU - Europa 3.413
AS - Asia 2.411
SA - Sud America 280
AF - Africa 134
OC - Oceania 62
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.455
Nazione #
US - Stati Uniti d'America 5.042
IT - Italia 1.399
SG - Singapore 771
CN - Cina 635
IE - Irlanda 345
DE - Germania 302
SE - Svezia 270
GB - Regno Unito 230
BR - Brasile 222
JP - Giappone 158
IN - India 146
FR - Francia 138
FI - Finlandia 135
AT - Austria 124
VN - Vietnam 98
HK - Hong Kong 94
ID - Indonesia 94
UA - Ucraina 94
KR - Corea 91
CA - Canada 75
SA - Arabia Saudita 65
NL - Olanda 64
PL - Polonia 55
AU - Australia 50
BE - Belgio 48
TR - Turchia 46
IQ - Iraq 41
IR - Iran 38
GR - Grecia 36
IL - Israele 32
SN - Senegal 30
ES - Italia 29
MX - Messico 29
TW - Taiwan 29
RU - Federazione Russa 28
PK - Pakistan 26
ET - Etiopia 22
ZA - Sudafrica 21
DK - Danimarca 20
CO - Colombia 19
UG - Uganda 18
NO - Norvegia 16
CH - Svizzera 14
BD - Bangladesh 13
MA - Marocco 13
NZ - Nuova Zelanda 12
RO - Romania 12
AR - Argentina 10
PE - Perù 10
SI - Slovenia 10
TN - Tunisia 10
PH - Filippine 9
CZ - Repubblica Ceca 7
HR - Croazia 7
EC - Ecuador 6
JO - Giordania 6
LT - Lituania 6
TH - Thailandia 6
CL - Cile 5
EG - Egitto 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
NG - Nigeria 4
PR - Porto Rico 4
RS - Serbia 4
VE - Venezuela 4
KE - Kenya 3
LU - Lussemburgo 3
PA - Panama 3
PT - Portogallo 3
ZM - Zambia 3
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GY - Guiana 2
MY - Malesia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
DZ - Algeria 1
EU - Europa 1
GH - Ghana 1
HU - Ungheria 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NP - Nepal 1
QA - Qatar 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 11.455
Città #
Chandler 849
Singapore 469
Santa Clara 393
Dublin 338
Torino 205
Beijing 190
Fairfield 180
Turin 180
Ashburn 151
Ann Arbor 134
Houston 120
Woodbridge 116
Sovicille 115
Nyköping 114
Vienna 106
Columbus 104
Redwood City 100
Jakarta 94
Seattle 92
Jacksonville 91
Wilmington 85
Cambridge 81
Princeton 81
Los Angeles 75
Medford 73
Pisa 71
Dong Ket 65
Guangzhou 64
Dearborn 62
Milan 61
Rome 61
Villeurbanne 59
Boston 50
Fremont 44
Munich 42
New York 42
Warsaw 42
Boardman 41
Tokyo 39
Hefei 38
Frankfurt am Main 36
Turku 36
Jeddah 35
Washington 33
Lappeenranta 29
Mumbai 29
Norwalk 26
Shanghai 26
Helsinki 25
Higashiayase 25
Hebei 24
Hong Kong 23
Addis Ababa 22
Maddaloni 22
San Diego 22
Taipei 22
Pittsburgh 21
Rochester 21
Nanjing 20
Birmingham 19
Brussels 19
São Paulo 19
Cardiff 18
Florence 18
Kampala 18
Seoul 18
Toronto 18
Wuhan 18
Genoa 17
London 17
New Delhi 17
Melbourne 16
Nuremberg 16
San Mauro Torinese 16
Elk Grove Village 15
Gongju 15
Hangzhou 15
Hyderabad 14
Novara 14
Sulaymaniyah 14
Ta'if 14
Thebes 14
Aarhus 13
Ipswich 13
Istanbul 13
Lahore 13
Ottawa 13
Stockholm 13
Bogotá 12
Chicago 12
Hanover 12
Johannesburg 12
Philadelphia 12
Piemonte 12
San Francisco 12
Berlin 11
Central 11
Dallas 11
Oslo 11
San Mateo 11
Totale 6.410
Nome #
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 440
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 337
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 297
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 276
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 264
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 251
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. 235
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 209
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 203
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 196
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 194
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 190
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 190
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 186
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 184
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 170
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 165
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 159
Strigolactone analogs are promising antiviral agents against Herpesviruses 153
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 152
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 147
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 147
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 142
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 142
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 140
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 138
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 137
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 135
Past and ongoing adaptation of human cytomegalovirus to its host. 133
A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. 131
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 130
Where do we stand after decades of studying human cytomegalovirus? 128
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 125
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 125
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 122
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 119
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 118
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 116
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 115
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 115
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 114
Tuning the Orchestra: HCMV vs. Innate Immunity. 114
Risk of Symptomatic Infection after Non-Primary Congenital Cytomegalovirus Infection 110
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 109
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 107
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 106
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 105
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 104
Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses [*Valentina Dell'Oste, Daniele Castagnolo: co-corresponding authors] 103
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 101
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 101
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 100
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 99
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 98
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 94
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 91
45th International Herpesvirus Workshop 88
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 87
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 87
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 86
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ 84
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 83
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 82
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 82
PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma 82
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 81
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 79
Targeting PAD-mediated citrullination to treat human papillomavirus infections 79
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 77
THE GENETIC VARIABILITY OF HUMAN CITOMEGALOVIRUS: POSSIBLE IMPLICATIONS IN CLINICAL, IMMUNOLOGICAL AND VIROLOGICAL SETTINGS 74
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 74
Exploring the urinary metabolomic fingerprint of human cytomegalovirus: a 1H-NMR study on congenitally infected newborns 74
50° Congresso Nazionale della Società Italiana di Microbiologia 71
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 70
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 70
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 70
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 69
Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection 69
STRIGOLACTONES FOR USE IN PREVENTING AND/OR TREATING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY 64
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 64
CONGENITAL CYTOEGALOVIRUS INFECTION: CAN THE DIFFERENCE BETWEEN THE VIRUS’ RELATIONSHIP WITH THE HOST’S IMMUNE SYSTEM EXPLAIN THE DIFFERENCE IN CLINICAL PHENOTYPES? 61
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 58
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 57
HERPES SIMPLEX VIRUS TYPE 1 EXPLOITS LIPID METABOLISM: IMPLICATIONS FOR VIRAL INFECTIVITY AND ALZHEIMER’S DISEASE 55
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 54
La variabilità genetica del citomegalovirus umano: possibili implicazioni dal punto di vista clinico, immunologico e virologico 54
Targeting PAD-mediated citrullination to treat human papillomavirus infections 51
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 51
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 49
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 48
Antimicrobial Efficacy of a Vegetable Oil Plasticizer in PVC Matrices 48
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 47
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 47
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 45
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 44
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 42
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 42
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 42
Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series [*Valentina Dell'Oste: corresponding author] 36
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer 32
Totale 11.521
Categoria #
all - tutte 36.540
article - articoli 0
book - libri 0
conference - conferenze 22.270
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020100 0 0 0 0 0 0 0 0 0 0 0 100
2020/20211.166 72 69 66 58 97 118 132 75 84 152 67 176
2021/20221.294 75 71 91 128 70 54 61 69 45 92 324 214
2022/20232.390 130 143 56 279 255 537 118 211 323 71 138 129
2023/20241.350 167 164 95 62 122 161 100 92 24 102 95 166
2024/20253.253 109 311 295 287 558 256 202 171 204 184 312 364
Totale 11.734